GlaxoSmithKline's expenditure on research and development by sector 2015-2019

This statistic shows the expenditure of the pharmaceutical company GlaxoSmithKline on research and development, from 2015 to 2019. In 2015, the company spent around 2.5 billion GBP for research and development within its pharmaceuticals segment. GlaxoSmithKline plc is a global pharmaceutical and biotech company, headquartered in London.

GlaxoSmithKline's expenditure on research and development from 2015 to 2019, by sector

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
in the first 12 months
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

March 2020

Region

Worldwide

Survey time period

2015 to 2019

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 / Month *
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical brands: Advair/Seretide (GlaxoSmithKline)"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.